Speaker illustration

Associate Professor Arantxa Gonzalez Miqueo

CIMA University of Navarre, Pamplona, Navarra (Spain)

Member of:

Heart Failure Association

Dr. González (PhD in Biochemistry 2003, University of Navarra, Spain) is the Director of the Program of Cardiovascular Disease (CIMA-Universidad de Navarra) and a group leader at the Spanish Cardiovascular Research Network (CIBERCV). She was granted the Norman R. Alpert Award in 2005 (ESC-AHA joint award). She was appointed as a Fellow of the Spanish Royal Academy of Science in 2023. She is also a member of the HFA Board since 2020 (Basic Science Section). Her research is focused on the study of myocardial remodelling in chronic heart failure, specially fibrosis, with a double aim: Identifying clinically useful non-invasive circulating biomarkers for improved diagnosis, risk stratification and personalized management; delving into fibrosis mechanisms to identify novel therapeutic targets. She has contributed to over 175 scientific publications (H index of 68) and she has led over 20 competitive research projects including National (Spanish) and European Commission-funded projects.

New therapeutic approaches in heart failure

Event: HFA Winter Research Meeting on Translational Heart Failure 2024

Topic: Drugs, Drug Targets

Session type: Symposium

Thumbnail

Cardioprotective effects of exercise: novel insights

Event: Heart Failure 2023

Topic: Cardiac Biology and Physiology

Session type: Symposium

Thumbnail

From bedside to bench and back

Event: Heart Failure 2023

Topic: Basic Science

Session type: Rapid Fire Abstracts

Thumbnail

Basic science - cardiac biology and physiology

Event: Heart Failure 2023

Topic: Basic Science

Session type: Moderated ePosters

Thumbnail

Basic science - cardiac disease 1

Event: Heart Failure 2023

Topic: Heart Failure

Session type: Moderated ePosters

Thumbnail

Young Investigator Award (YIA) Basic Science

Event: Heart Failure 2023

Topic: Basic Science

Session type: Award Sessions

Thumbnail

Precision medicine: gene editing - RNA therapeutics and the first steps in the clinic

Event: HFA Winter Research Meeting on Translational Heart Failure 2023

Topic: Drugs, Drug Targets

Session type: Symposium

Thumbnail

New targets for the treatment of heart failure with preserved ejection fraction

Event: Heart Failure 2022

Topic: Heart Failure

Session type: Symposium

Thumbnail

HoT session – HFrEF treatment: not so easy as it seems, Part 2

Event: Heart Failure 2021

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Cardiac tissue engineering from bench to bedside: are we ready?

Event: Heart Failure 2021

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb